Pacira | PCRX - Current Liabilities


Pacira reported $122.01M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Astellas Pharma JPY 1.22T 106.19B Mar/2026
Bristol-Myers Squibb USD 18.66B 499M Jun/2026
Cara Therapeutics USD 11.26M 216K Mar/2026
Coherus Biosciences USD 140.39M 231.91M Dec/2025
Heron Therapeutics USD 90.52M 5.58M Mar/2026
Ironwood Pharmaceuticals USD 236.31M 5.91M Mar/2026
J&J USD 54.9B 2.82B Jun/2026
Ligand Pharmaceuticals USD 40.67M 3.22M Mar/2026
Nektar Therapeutics USD 57.71M 4.17M Mar/2026
Novo Nordisk DKK 225.16B 9.5B Mar/2026
Omeros USD 85.5M 2.28M Jun/2025
Pacira USD 122.01M 13.22M Jun/2026
Perrigo USD 997.6M 15.3M Mar/2026
Pfizer USD 32.65B 1.7B Jun/2026
Supernus Pharmaceuticals USD 347.38M 26.55M Jun/2026
Teva Pharmaceutical Industries USD 15.65B 2.11B Jun/2026
Xeris Pharmaceuticals USD 118.59M 9.02M Mar/2026
Zoetis USD 2.05B 182M Mar/2026